Published in Proc Natl Acad Sci U S A on January 31, 2005
Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet (2008) 4.71
DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet (2012) 3.17
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol Psychiatry (2012) 2.07
Epigenetics and human disease: translating basic biology into clinical applications. CMAJ (2006) 1.98
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) (2005) 1.82
The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci U S A (2006) 1.71
GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One (2007) 1.66
Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci U S A (2005) 1.56
Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci U S A (2007) 1.51
Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull (2009) 1.47
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology (2010) 1.41
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
Increased Blood-Reelin-Levels in First Episode Schizophrenia. PLoS One (2015) 1.38
Hippocampal neuroplasticity induced by early-life stress: functional and molecular aspects. Front Neuroendocrinol (2006) 1.37
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res (2007) 1.34
Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res (2007) 1.25
Epigenetics of major psychosis: progress, problems and perspectives. Trends Genet (2012) 1.24
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology (2012) 1.21
Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev (2009) 1.17
Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta (2009) 1.17
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology (2011) 1.17
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front Cell Neurosci (2013) 1.12
Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology (2010) 1.11
Epigenetics in the human brain. Neuropsychopharmacology (2012) 1.08
Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Transl Psychiatry (2012) 1.08
An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes. Schizophr Res (2009) 1.04
Extracellular matrix abnormalities in schizophrenia. Neuropharmacology (2011) 1.04
Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res (2008) 1.04
DNA methylation signatures for breast cancer classification and prognosis. Genome Med (2012) 1.01
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry (2013) 1.00
Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci (2009) 0.99
Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci U S A (2010) 0.97
An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouse. Genome Biol (2013) 0.97
The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation. Toxicol Sci (2011) 0.96
Epigenetics and psychiatry. Neurotherapeutics (2013) 0.96
Global DNA hypermethylation in down syndrome placenta. PLoS Genet (2013) 0.95
Active DNA demethylation in post-mitotic neurons: a reason for optimism. Neuropharmacology (2013) 0.94
Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab (2013) 0.93
Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation. Neurobiol Learn Mem (2011) 0.93
DNA methylation-mediated control of learning and memory. Mol Brain (2011) 0.92
DNA methylation changes in the postmortem dorsolateral prefrontal cortex of patients with schizophrenia. Front Genet (2014) 0.91
Chromatin, DNA methylation and neuron gene regulation--the purpose of the package. J Psychiatry Neurosci (2005) 0.91
Toward the identification of peripheral epigenetic biomarkers of schizophrenia. J Neurogenet (2014) 0.91
DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophr Res (2014) 0.90
CpG methylation in neurons: message, memory, or mask? Neuropsychopharmacology (2010) 0.89
Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia. Front Behav Neurosci (2013) 0.89
The molecular pathology of schizophrenia--focus on histone and DNA modifications. Brain Res Bull (2009) 0.89
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis. Front Cell Neurosci (2013) 0.87
DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67-positive neurons in the GAD67-GFP mouse brain. J Comp Neurol (2012) 0.86
Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons. Neuropsychopharmacology (2011) 0.86
DNA methylation and demethylation as targets for antipsychotic therapy. Dialogues Clin Neurosci (2014) 0.86
Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia. J Neural Transm (Vienna) (2008) 0.85
Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia. Schizophr Res (2014) 0.85
Epigenetic mechanisms in the development of behavior: advances, challenges, and future promises of a new field. Dev Psychopathol (2013) 0.84
Prospects for the development of epigenetic drugs for CNS conditions. Nat Rev Drug Discov (2015) 0.82
Epigenetics of neural repair following spinal cord injury. Neurotherapeutics (2013) 0.81
Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit. Differentiation (2011) 0.80
Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovasc Psychiatry Neurol (2009) 0.80
Expression of DNA methyltransferases in adult dorsal root ganglia is cell-type specific and up regulated in a rodent model of neuropathic pain. Front Cell Neurosci (2014) 0.79
Epigenetic management of major psychosis. Clin Epigenetics (2011) 0.79
N-methyl-D-aspartate receptor expression in parvalbumin-containing inhibitory neurons in the prefrontal cortex in bipolar disorder. Bipolar Disord (2010) 0.79
Neuropathology of mood disorders: do we see the stigmata of inflammation? Transl Psychiatry (2016) 0.78
Modeling the molecular epigenetic profile of psychosis in prenatally stressed mice. Prog Mol Biol Transl Sci (2014) 0.78
The role of DNA methylation in the pathophysiology and treatment of bipolar disorder. Neurosci Biobehav Rev (2016) 0.78
Maintenance time of sedative effects after an intravenous infusion of diazepam: a guide for endoscopy using diazepam. World J Gastroenterol (2008) 0.78
Longitudinal epigenetic variation of DNA methyltransferase genes is associated with vulnerability to post-traumatic stress disorder. Psychol Med (2014) 0.77
Epigenetics, behaviour, and health. Allergy Asthma Clin Immunol (2008) 0.77
Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus. J Psychiatr Res (2013) 0.77
A neurochemical basis for an epigenetic vision of psychiatric disorders (1994-2009). Pharmacol Res (2011) 0.77
From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. Front Neurosci (2016) 0.77
Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. Schizophr Res (2015) 0.76
Stem Cell Models to Investigate the Role of DNA Methylation Machinery in Development of Neuropsychiatric Disorders. Stem Cells Int (2015) 0.75
Theranostic Biomarkers for Schizophrenia. Int J Mol Sci (2017) 0.75
Differential SLC1A2 Promoter Methylation in Bipolar Disorder With or Without Addiction. Front Cell Neurosci (2017) 0.75
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem (2001) 6.85
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A (2001) 6.68
Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry (2000) 5.12
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology (2001) 4.41
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry (2000) 3.44
A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A (1998) 3.33
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology (2003) 2.46
Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry (2004) 2.37
Three-dimensional counting: an accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol (1988) 2.26
Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry (2000) 2.10
Valproate induces replication-independent active DNA demethylation. J Biol Chem (2003) 2.02
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A (1998) 2.00
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A (2002) 1.91
Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. Cereb Cortex (1993) 1.90
Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) (2003) 1.86
DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci U S A (2003) 1.71
On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res (2002) 1.69
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry (2003) 1.68
The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry (2004) 1.63
GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol (2003) 1.59
GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry (2001) 1.55
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol Interv (2002) 1.49
In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. J Comp Neurol (2002) 1.07
Doxorubicin inhibits DNMT1, resulting in conditional apoptosis. Mol Pharmacol (2004) 1.01
Application and optimization of microarray technologies for human postmortem brain studies. Biol Psychiatry (2004) 0.97
GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol (2003) 0.94
GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology (2004) 0.83
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet (2008) 10.20
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet (2013) 8.20
Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet (2007) 7.85
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet (2012) 4.59
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials. Schizophr Res (2011) 4.22
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry (2012) 3.29
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis. Schizophr Res (2010) 3.26
Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A (2005) 3.12
n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr (2010) 3.09
Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry (2006) 3.01
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry (2012) 2.61
A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry (2008) 2.53
Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull (2010) 2.50
The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum (2007) 2.25
Mortality trends in rheumatoid arthritis: the role of rheumatoid factor. J Rheumatol (2008) 2.02
Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci U S A (2006) 2.01
DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol (2006) 1.95
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Decoding the massive genome of loblolly pine using haploid DNA and novel assembly strategies. Genome Biol (2014) 1.90
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry (2012) 1.85
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berl) (2005) 1.82
The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol (2011) 1.82
Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum (2007) 1.76
Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry (2007) 1.75
The choice of drugs for schizophrenia. N Engl J Med (2006) 1.75
Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry (2005) 1.74
Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics (2007) 1.70
On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res (2002) 1.69
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia. Am J Psychiatry (2002) 1.55
Evolution of genome size and complexity in Pinus. PLoS One (2009) 1.52
Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl) (2006) 1.48
The use of depot medications in the treatment of schizophrenia. Am J Psychiatry (2010) 1.43
Priming defense genes and metabolites in hybrid poplar by the green leaf volatile cis-3-hexenyl acetate. New Phytol (2008) 1.40
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc Natl Acad Sci U S A (2003) 1.38
Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res (2007) 1.34
Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology (2007) 1.34
The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther (2006) 1.32
Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 1.30
Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev (2012) 1.29
DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci U S A (2005) 1.26
Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. Proc Natl Acad Sci U S A (2007) 1.23
The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol (2008) 1.22
Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proc Natl Acad Sci U S A (2008) 1.22
Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology (2012) 1.21
Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics (2010) 1.20
Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry (2006) 1.19
Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr Res (2006) 1.18
Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci (2008) 1.17
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology (2011) 1.17
S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport (2007) 1.17
High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology (2009) 1.16
Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem (2005) 1.16
SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol (2009) 1.15
Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology (2004) 1.15
Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14
In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci U S A (2003) 1.14
Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas. Clin Schizophr Relat Psychoses (2012) 1.12
Proton magnetic resonance spectroscopy and illness stage in schizophrenia--a systematic review and meta-analysis. Biol Psychiatry (2010) 1.11
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder. Schizophr Res (2009) 1.11
Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull (2014) 1.11
In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. J Comp Neurol (2002) 1.07
All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis. J Clin Psychopharmacol (2007) 1.07
Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol (2010) 1.04
Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice. Neurochem Res (2008) 1.03
Transcript profiles of the cytokinin response regulator gene family in Populus imply diverse roles in plant development. New Phytol (2007) 1.03
Performance of a self-report measure of the level of response to alcohol in 12- to 13-year-old adolescents. J Stud Alcohol (2005) 1.02
The cytokinin type-B response regulator PtRR13 is a negative regulator of adventitious root development in Populus. Plant Physiol (2009) 1.02
The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr Opin Pharmacol (2002) 1.02
Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis (2010) 1.01
Association mapping of quantitative disease resistance in a natural population of loblolly pine (Pinus taeda L.). Genetics (2010) 1.00
Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids (2009) 1.00
MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol (2011) 1.00
Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep (2010) 1.00
Evidence-based pharmacotherapy of schizophrenia. Int J Neuropsychopharmacol (2011) 0.99
Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology (2011) 0.99
Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev (2006) 0.99